End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
91,000 KRW | -0.22% | -3.29% | +34.22% |
2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
Sales 2024 * | 329B 237M | Sales 2025 * | 377B 272M | Capitalization | 1,758B 1.27B |
---|---|---|---|---|---|
Net income 2024 * | 37B 26.71M | Net income 2025 * | 59B 42.6M | EV / Sales 2024 * | 5.66 x |
Net Debt 2024 * | 105B 75.45M | Net Debt 2025 * | 97.68B 70.53M | EV / Sales 2025 * | 4.92 x |
P/E ratio 2024 * |
45
x | P/E ratio 2025 * |
28.4
x | Employees | 645 |
Yield 2024 * |
0.55% | Yield 2025 * |
0.55% | Free-Float | 54.24% |
1 day | -0.22% | ||
1 week | -3.29% | ||
1 month | -2.57% | ||
3 months | +43.08% | ||
6 months | +43.08% | ||
Current year | +34.22% |
Managers | Title | Age | Since |
---|---|---|---|
Gyeong-Jin Kim
CEO | Chief Executive Officer | 61 | 17-03-16 |
Kyung-Eun Jung
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Hyun-Min Lee
BRD | Director/Board Member | 51 | 19-03-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gyeong-Jin Kim
CEO | Chief Executive Officer | 61 | 17-03-16 |
Hyeong-Jun An
BRD | Director/Board Member | 60 | 18-03-15 |
Hyun-Min Lee
BRD | Director/Board Member | 51 | 19-03-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.43% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +5.36% | - | |
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 91,000 | -0.22% | 117,899 |
24-05-30 | 91,200 | +1.90% | 100,276 |
24-05-29 | 89,500 | -4.07% | 170,167 |
24-05-28 | 93,300 | +4.25% | 311,461 |
24-05-27 | 89,500 | -4.89% | 402,234 |
End-of-day quote Korea S.E., May 30, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.22% | 1.27B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- A237690 Stock